ChemNet > CAS > 131929-60-7 spinosad

131929-60-7;168316-95-8 spinosad

Nome del prodotto	spinosad
Nome inglese	spinosad; spinosyn D; (2R,3aS,5aR,5bS,9S,14R,16aS,16bR)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranoside; (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranoside; (5aR,5bS,14R,16bR)-13-{[5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methylhexopyranoside; Mixture of Spinosyn A and Spinosyn D; 2-d)oxacyclododecin-7,15-dione,2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-((5-dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl);
Formula molecolare	C₄₁H₆₅NO₁₀
Peso Molecolare	731.9555
InChI	InChI=1/C41H65NO10/c1-10-26-12-11-13-34(52-36-17-16-33(42(5)6)23(3)48-36)22(2)37(44)32-20-30-28(31(32)21-35(43)50-26)15-14-25-18-27(19-29(25)30)51-41-40(47-9)39(46-8)38(45-7)24(4)49-41/h14-15,20,22-31,33-34,36,38-41H,10-13,16-19,21H2,1-9H3/t22-,23?,24?,25?,26?,27?,28-,29-,30?,31+,33?,34?,36?,38?,39?,40?,41?/m1/s1
Numero CAS	131929-60-7;168316-95-8
Struttura molecolare
Densità	1.167g/cm³
Punto di ebollizione	801.515°C at 760 mmHg
Indice di rifrazione	1.54
Punto d'infiammabilità	438.541°C
Pressione di vapore	0mmHg at 25°C

Chemicals Suppliers(12):: 1Jiangsu Lingyun Pharmaceutical Co., Ltd.; 2AVF Chemical Industrial CO.,LTD; 3AFINE CHEMICALS LIMITED; 4Taizhou Crene Biotechnology Co., Ltd.; 5Capot Chemical Co., Ltd.; 6Hangzhou Shuyuan Pharmaceutical Technology Co., Ltd.; 7Jiangxi Anlida Chemical Co., Ltd.; 8Shanghai Neopharm Co., Ltd.; 9Guangxi QILI Pharmaceutical Co.,ltd.; 10Fuzhou Contay biotechnology Co.,Ltd.; Contact Suppliers; Post Buying Leads; Related selling offers

潘金莲被吸乳揉到高潮的视频,久久99久久99精品免观看,在电影院里拨开内裤挺进,护士交换粗吟配乱大交动态图

131929-60-7;168316-95-8 spinosad